| In-patient, n/N (%) | Out-patient, n/N (%) | OR (95% CI) | p-value |
---|---|---|---|---|
A. Main antibiotic groups | ||||
 Aminoglycosides | 403/1432 (28.1) | 478/1637 (29.2) | 0.96 (0.83–1.12) | 0.631 |
 Sulfonamides | 610/1021 (59.7) | 509/867 (58.7) | 1.02 (0.88–1.18) | 0.817 |
 Cyclines | 416/614 (67.8) | 82/107 (76.6) | 0.88 (0.65–1.21) | 0.441 |
 Fosfomycin | 0 | 9/107 (8.4) | 11.3 (0.21–603.0) | 0.232 |
 Nitrofurans | 130/952 (13.7) | 167/534 (31.3) | 0.44 (0.34–0.56) | < 0.0001 |
 Quinolones | 1333/2217 (60.1) | 623/1739 (35.8) | 1.68 (1.50–1.88) | < 0.0001 |
 Beta-lactams | 2244/5622 (39.9) | 2166/6342 (34.2) | 0.86 (0.80–0.92) | < 0.0001 |
B. Beta-lactams classes | ||||
 Aminopenicillins | 846/1117 (75.7) | 311/440 (70.7) | 1.07 (0.90–1.27) | 0.427 |
 Carbapenems | 2/659 (0.3) | 5/689 (0.7) | 0.41 (0.8–2.16) | 0.298 |
 Monobactams | 77/150 (51.3) | 1/204 (0.5) | 104.7 (14.4–761.4) | < 0.0001 |
 Beta-lactam+Inhibitors | 273/754 (36.2) | 331/796 (41.6) | 0.87 (0.72–1.05) | 0.150 |
 Cephalosporins | 1046/2942 (35.6) | 1518/4213 (36.0) | 1.01 (0.93–1.11) | 0.776 |
C. Cephalosporins classes | ||||
 1GCs | 210/491 (42.8) | 160/462 (34.6) | 1.24 (0.97–1.57) | 0.087 |
 2GCs | 118/518 (22.8) | 375/894 (41.9) | 0.54 (0.43–0.69) | < 0.0001 |
 3GCs | 571/1648 (34.7) | 850/2190 (38.8) | 0.89 (0.89–1.01) | 0.072 |
 4GCs | 147/285 (51.6) | 133/667 (19.9) | 2.59 (1.97–3.40) | < 0.0001 |
D. Virulence factors groups | ||||
 Adhesins | 1635/3309 (49.4) | 681/1739 (39.2) | 1.3 (1.13–1.40) | < 0.0001 |
 Siderophore systems | 276/428 (64.5) | 371/1121 (33.1) | 1.9 (1.61–2.36) | < 0.0001 |
 Toxins | 312/1418 (22.0) | 217/1246 (17.4) | 1.3 (1.05–1.53) | 0.016 |
 Immune suppressors | 200/276 (72.5) | 674/1339 (50.3) | 1.4 (1.17–1.77) | 0.001 |